Related Experiment Video
Updated: Jun 24, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Thalassaemic bone disease. An overview
Michael Angastiniotis1, Androulla Eleftheriou
1Thalassaemia International Federation, Nicosia, Cyprus.
Insights
Thalassaemic bone disease results from multiple factors, yet lacks standardized investigation and evidence-based management protocols. Further research is needed to document its natural history and long-term therapeutic effects.
Area of Science:
- Hematology
- Orthopedics
- Metabolic Bone Disease
Background:
- Thalassaemic bone disease is a complex condition with multiple contributing factors.
- These factors can vary in type and severity among patients.
- Current understanding necessitates a tailored management approach for each individual.
Purpose of the Study:
- To review the literature on causative influences in thalassaemic bone disease.
- To critically examine current investigation and management strategies.
- To highlight the lack of standardized protocols for this condition.
Main Methods:
- Literature review of causative factors in thalassaemic bone disease.
- Critical analysis of existing investigational methods.
- Evaluation of current management strategies based on available evidence.
Main Results:
- Multiple factors contribute to bone damage in thalassaemia.
- There is a lack of consensus on investigation protocols.
- Evidence-based management guidelines are currently unavailable.
Conclusions:
- A significant gap exists in agreed guidelines for investigating and monitoring thalassaemia patients.
- There is a need for evidence-based management protocols for lifelong bone disease in thalassaemia.
- The natural history and long-term effects of therapy for this complex osteopathy require further documentation.
Abstract:
Thalassaemic bone disease is a composite entity in which structural damage to bone is brought about by several influences, each of which may affect the bone in a different way and to a variable degree, but which may co-exist in individual patients. Understanding these damaging factors in each patient should lead to an orthologistic approach to management. However there is currently no agreed investigational protocol for the elucidation of these factors and no evidence based protocol for management. In this article the role of each of the causative influences is reviewed according to current literature and a critical examination of investigation and management is made. The conclusion is that there is a lack of agreed guidelines for the investigation and monitoring of thalassaemia patients and a lack of evidence based protocol for management of patients whose bone disease starts at an early age and continues for the rest of their lives. The natural history of this complex osteopathy and the long term effects of therapy are not well documented.
Related Concept Videos
What is the Skeletal System?
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The Functions of the Skeletal System
Skeleton and Calcium Homeostasis
